viernes, 4 de mayo de 2012

Metabolomic Profile of Human Myocardial Ischemia by Nuclear Magnetic Resonance Spectroscopy of Peripheral Blood Serum: A Translational Study Based on Transient Coronary Occlusion Models -- Bodi et al. 59 (18): 1629 -- Journal of the American College of Cardiology

Metabolomic Profile of Human Myocardial Ischemia by Nuclear Magnetic Resonance Spectroscopy of Peripheral Blood Serum: A Translational Study Based on Transient Coronary Occlusion Models -- Bodi et al. 59 (18): 1629 -- Journal of the American College of Cardiology

J Am Coll Cardiol, 2012; 59:1629-1641, doi:10.1016/j.jacc.2011.09.083
© 2012 by the American College of Cardiology Foundation























































CLINICAL RESEARCH: CARDIAC IMAGING


Metabolomic Profile of Human Myocardial Ischemia by Nuclear Magnetic Resonance Spectroscopy of Peripheral Blood Serum

A Translational Study Based on Transient Coronary Occlusion Models

Vicente Bodi, MD*,*, Juan Sanchis, MD*, Jose M. Morales, BSc{dagger}, Vannina G. Marrachelli, PhD*, Julio Nunez, MD*, Maria J. Forteza, BSc*, Fabian Chaustre, BSc*, Cristina Gomez, BSc*, Luis Mainar, MD*, Gema Minana, MD*, Eva Rumiz, MD*, Oliver Husser, MD*, Inmaculada Noguera, PhD{dagger}, Ana Diaz, PhD{dagger}, David Moratal, PhD{ddagger}, Arturo Carratala, MD§, Xavier Bosch, MD||, Angel Llacer, MD*, Francisco J. Chorro, MD*, Juan R. Viña, MD, PhD,# and Daniel Monleon, PhD#,* * Cardiology Department, Hospital Clinico Universitario-INCLIVA, Universidad de Valencia, Valencia, Spain
{dagger} Unidad Central de Investigación en Medicina, Universidad de Valencia, Valencia, Spain
{ddagger} Centro de Biomateriales e Ingeniería Tisular, Universidad Politécnica de Valencia, Valencia, Spain
§ Department of Clinical Analyses, Hospital Clinico Universitario-INCLIVA, Valencia, Spain
|| Cardiology Department, Hospital Clínic, IDIBAPS, Universidad de Barcelona, Barcelona, Spain
Department of Biochemistry and Molecular Biology, Facultad de Medicina, Universidad de Valencia, Valencia, Spain
# Fundación Investigación, Hospital Clinico Universitario-INCLIVA, Valencia, Spain
Manuscript received August 4, 2011; accepted September 25, 2011.
* Reprint requests and correspondence: Dr. Vicente Bodi, Cardiology Department, and/or Dr. Daniel Monleon, Fundacion de Investigacion, Hospital Clinico Universitario-INCLIVA, Universidad de Valencia, Blasco Ibanez 17, 46010 Valencia, Spain (Email: vicentbodi@hotmail.com or daniel.monleon@uv.es).

Objectives: The aim of this study was to investigate the metabolomic profile of acute myocardial ischemia (MIS) using nuclear magnetic resonance spectroscopy of peripheral blood serum of swine and patients undergoing angioplasty balloon–induced transient coronary occlusion.

Background: Biochemical detection of MIS is a major challenge. The validation of novel biosignatures is of utmost importance.

Methods: High-resolution nuclear magnetic resonance spectroscopy was used to profile 32 blood serum metabolites obtained (before and after controlled ischemia) from swine (n = 9) and patients (n = 20) undergoing transitory MIS in the setting of planned coronary angioplasty. Additionally, blood serum of control patients (n = 10) was sequentially profiled. Preliminary clinical validation of the developed metabolomic biosignature was undertaken in patients with spontaneous acute chest pain (n = 30).

Results: Striking differences were detected in the blood profiles of swine and patients immediately after MIS. MIS induced early increases (10 min) of circulating glucose, lactate, glutamine, glycine, glycerol, phenylalanine, tyrosine, and phosphoethanolamine; decreases in choline-containing compounds and triacylglycerols; and a change in the pattern of total, esterified, and nonesterified fatty acids. Creatine increased 2 h after ischemia. Using multivariate analyses, a biosignature was developed that accurately detected patients with MIS both in the setting of angioplasty-related MIS (area under the curve 0.94) and in patients with acute chest pain (negative predictive value 95%).

Conclusions: This study reports, to the authors' knowledge, the first metabolic biosignature of acute MIS developed under highly controlled coronary flow restriction. Metabolic profiling of blood plasma appears to be a promising approach for the early detection of MIS in patients.

Key Words: metabolomics • myocardial ischemia • nuclear magnetic resonance
Abbreviations and Acronyms
  FA = fatty acid
  MIS = myocardial ischemia
  NMR = nuclear magnetic resonance
  PCA = principal component analysis
  PLS-DA = projection to latent structures for discriminant analysis


Related Articles

Metabolomics: Seeking a Unique Biomarker Signature for Coronary Artery Syndromes
Ronald W. Millard and Paul R. Rosevear J. Am. Coll. Cardiol. 2012 59: 1642-1644. [Full Text] [PDF]

Inside This Issue
J. Am. Coll. Cardiol. 2012 59: A23-A26. [Full Text] [PDF]

No hay comentarios:

Publicar un comentario